UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjogren's syndrome (pSS): a European multicentre study
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Article
  • Authors:
    Tzioufas AG, Wassmuth R, Dafni UG, Guialis A, Haga HJ, Isenberg DA, Jonsson R, Kalden JR, Kiener H, Sakarellos C, Smolen JS, Sutcliffe N, Vitali C, Yiannaki E, Moutsopoulos HM
  • Publication date:
    05/2002
  • Pagination:
    398, 404
  • Journal:
    Annals of the Rheumatic Diseases
  • Volume:
    61
  • Issue:
    5
  • Print ISSN:
    0003-4967
  • Keywords:
    ACID, Aged, Allele, Alleles, amino acid, analogue, analysis, antibodies, Antibody, Antibody Formation, ANTIGEN, Antigens, As, ASSAY, Association, Autoantibodies, Autoantigens, autoimmune, B CELL, B-cell, B-Lymphocytes, BINDING, cell, clinical, comparison, control, DETERMINANT, DETERMINANTS, discrete, disease, Disease Susceptibility, DNA, domain, DQA1, DURATION, enlargement, EPITOPE, Epitopes, Europe, european, Female, formation, FREQUENCIES, FREQUENCY, Genotype, genotypes, HLA, HLA-DQ Antigens, IM, immunology, LA, Laboratories, laboratory, LINEAR, Low, LOW-FREQUENCY, Male, MANIFESTATIONS, May, Methods, Middle Age, model, MULTICENTER, Multicenter Studies, MULTICENTRE, Patient, patients, peptide, Peptides, positive, Precipitation, Prevalence, production, PROTEIN, RANGE, RECURRENT, REGION, response, Result, Ribonucleoproteins, Rna, SAMPLE, SAMPLES, SEQUENCE, SERA, serum, Sjogren's Syndrome, Support, Non-U.S.Gov't, Syndrome, synthetic
  • Notes:
    UI - 21955966 LA - eng RN - 0 (Autoantibodies) RN - 0 (Autoantigens) RN - 0 (Epitopes) RN - 0 (HLA-DQ Antigens) RN - 0 (Ribonucleoproteins) RN - 0 (SS-A antigen) RN - 0 (SS-B antigen) PT - Journal Article PT - Multicenter Study DA - 20020417 IS - 0003-4967 SB - IM CY - England
Abstract
OBJECTIVES: To investigate the clinical and immunogenetic aspects of antibody formation against Ro/SSA and La/SSB as well as their linear B cell epitopes in patients with primary Sjogren's syndrome (pSS) from different European countries. PATIENTS AND METHODS: Ninety patients with pSS from six European centres were studied. Serum samples from all patients were tested in a control laboratory for anti-Ro/SSA and anti- La/SSB autoantibodies by RNA precipitation assay and autoantibodies to the previously reported B cell linear epitopes of Ro 60 kDa (p169-190aa and p211-232aa) and La/SSB (p147-154aa, p291-302aa, p301-318aa, and p349-364aa). DNA from 88 patients was used for the determination of HLA- DRB1, -DQA1, and -DQB1 genotypes. Analysis of the results was performed in the 88 patients who were genotyped and tested also for antipeptide antibodies. RESULTS: Antibodies to B cell epitopes of Ro 60 kDa were detected at a low frequency (range 10-37%). In contrast, B cell epitopes of La/SSB were detected frequently (range 58-86%) among the anti-La/SSB positive sera. Autoantibodies to the La/SSB epitope, p349- 364aa, were significantly positively associated with longer disease duration (p<0.05), recurrent or permanent parotid gland enlargement (p<0.005), and a higher proportion of non-exocrine manifestations (p<0.005), compared with patients without autoantibodies. The presence of anti-Ro/SSA and anti-La/SSB autoantibodies was significantly associated with the presence of HLA-DRB1*03 and DQB1*02 (p=0.038 and p=0.034, respectively). This association was even more prominent and extended to HLA-DQA1*0501 when patients were stratified according the presence of autoantibodies to discrete La/SSB B cell epitopes in comparison with autoantibody negative patients (p<0.01). They were found also to be highly associated with the alleles HLA-DQB1*02 and HLA- DQA1*0501 as well as the presence of a shared amino acid motif in the region 59-69aa of DQB1 first domain (p<0.01, respectively). CONCLUSIONS: Autoantibodies against La/SSB, binding to four synthetic peptides, derived from the sequence of the La protein were identified with increased frequency in sera of patients with pSS. The formation of autoantibodies against B cell epitope analogues of La/SSB in European patients with pSS may be dependent on the presence of a permissive HLA- DQ heterodimer, most prominently represented by the HLA- DQA1*0501/DQB1*0201 heterodimer, suggesting that a model of HLA restricted presentation of La/SSB peptide determinants is crucial for the autoimmune response against La/SSB
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by